;PMID: 9797369
;source_file_1390.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..41] = [t:0..41]
;1)sentence:[e:46..108] = [t:46..108]
;2)section:[e:112..167] = [t:112..167]
;3)section:[e:171..305] = [t:171..305]
;4)sentence:[e:309..327] = [t:309..327]
;5)sentence:[e:328..484] = [t:328..484]
;6)sentence:[e:485..593] = [t:485..593]
;7)sentence:[e:594..602] = [t:594..602]
;8)sentence:[e:603..722] = [t:603..722]
;9)sentence:[e:723..880] = [t:723..880]
;10)sentence:[e:881..889] = [t:881..889]
;11)sentence:[e:890..1033] = [t:890..1033]
;12)sentence:[e:1034..1207] = [t:1034..1207]
;13)sentence:[e:1208..1437] = [t:1208..1437]
;14)sentence:[e:1438..1585] = [t:1438..1585]
;15)sentence:[e:1586..1598] = [t:1586..1598]
;16)sentence:[e:1599..1712] = [t:1599..1712]
;17)section:[e:1716..1760] = [t:1716..1760]

;section 0 Span:0..41
;Gastroenterology  1998 Nov;115(5):1144-53
(SEC
  (FRAG (IN:[0..16] Gastroenterology) (CD:[18..22] 1998)
        (CD:[23..31] Nov;115-LRB-) (CD:[31..32] 5) (-RRB-:[32..33] -RRB-)
        (CD:[33..38] :1144) (IN:[38..39] -) (CD:[39..41] 53)))

;sentence 1 Span:46..108
;Oncogenic ras induces gastrin gene expression in colon cancer.
;[56..59]:gene-rna:"ras"
;[68..75]:gene-generic:"gastrin"
;[95..107]:malignancy:"colon cancer"
(SENT
  (S-HLN
    (NP-SBJ (JJ:[46..55] Oncogenic) (NN:[56..59] ras))
    (VP (VBZ:[60..67] induces)
      (NP (NN:[68..75] gastrin) (NN:[76..80] gene) (NN:[81..91] expression))
      (PP (IN:[92..94] in)
        (NP (NN:[95..100] colon) (NN:[101..107] cancer))))
    (.:[107..108] .)))

;section 2 Span:112..167
;Nakata H, Wang SL, Chung DC, Westwick JK, Tillotson LG.
(SEC
  (FRAG (NNP:[112..118] Nakata) (NNP:[119..120] H) (,:[120..121] ,)
        (NNP:[122..126] Wang) (NNP:[127..129] SL) (NNP:[129..130] ,)
        (NNP:[131..136] Chung) (NNP:[137..139] DC) (,:[139..140] ,)
        (NNP:[141..149] Westwick) (NNP:[150..152] JK) (,:[152..153] ,)
        (NNP:[154..163] Tillotson) (NNP:[164..167] LG.)))

;section 3 Span:171..305
;Division of Digestive Diseases and Nutrition, Department of Medicine,
;University  of North Carolina, Chapel Hill, North Carolina, USA.
(SEC
  (FRAG (NNP:[171..179] Division) (CD:[180..182] of) (NNP:[183..192] Digestive)
        (NNP:[193..201] Diseases) (CC:[202..205] and) (NNP:[206..215] Nutrition)
        (,:[215..216] ,) (NNP:[217..227] Department) (IN:[228..230] of)
        (NNP:[231..239] Medicine) (,:[239..240] ,) (NNP:[241..251] University)
        (IN:[253..255] of) (NNP:[256..261] North) (NNP:[262..270] Carolina)
        (,:[270..271] ,) (NNP:[272..278] Chapel) (NNP:[279..283] Hill)
        (,:[283..284] ,) (NNP:[285..290] North) (NNP:[291..299] Carolina)
        (,:[299..300] ,) (NNP:[301..304] USA) (.:[304..305] .)))

;sentence 4 Span:309..327
;BACKGROUND & AIMS:
(SENT
  (NP (NN:[309..319] BACKGROUND) (CC:[320..321] &) (NNS:[322..326] AIMS)
      (::[326..327] :)))

;sentence 5 Span:328..484
;The expression of gastrin, as a tumor growth factor, is  significantly
;increased in some colon cancers compared with the low levels found  in normal
;mucosa.
;[346..353]:gene-protein:"gastrin"
;[360..379]:gene-protein:"tumor growth factor"
;[417..430]:malignancy:"colon cancers"
(SENT
  (S
    (NP-SBJ-2
      (NP (DT:[328..331] The) (NN:[332..342] expression))
      (PP (IN:[343..345] of)
        (NP (NN:[346..353] gastrin)))
      (,:[353..354] ,)
      (PP (IN:[355..357] as)
        (NP (DT:[358..359] a)
           (NN:[360..365] tumor) (NN:[366..372] growth) (NN:[373..379] factor))))
    (,:[379..380] ,)
    (VP (VBZ:[381..383] is)
      (ADVP (RB:[385..398] significantly))
      (VP (VBN:[399..408] increased)
        (NP-2 (-NONE-:[408..408] *))
        (PP (IN:[409..411] in)
          (NP (DT:[412..416] some)
             (NN:[417..422] colon) (NNS:[423..430] cancers)))
        (S-ADV
          (NP-SBJ-1 (-NONE-:[430..430] *))
          (VP (VBN:[431..439] compared)
            (NP-1 (-NONE-:[439..439] *))
            (PP-CLR (IN:[440..444] with)
              (NP
                (NP (DT:[445..448] the) (JJ:[449..452] low)
                    (NNS:[453..459] levels))
                (VP (VBN:[460..465] found)
                  (NP (-NONE-:[465..465] *))
                  (PP (IN:[467..469] in)
                    (NP (JJ:[470..476] normal) (NN:[477..483] mucosa))))))))))
    (.:[483..484] .)))

;sentence 6 Span:485..593
;The aim of this study was to elucidate the transcriptional  mechanisms of
;gastrin induction in colon cancer.
;[559..566]:gene-generic:"gastrin"
;[580..592]:malignancy:"colon cancer"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[485..488] The) (NN:[489..492] aim))
      (PP (IN:[493..495] of)
        (NP (DT:[496..500] this) (NN:[501..506] study))))
    (VP (VBD:[507..510] was)
      (S-NOM-PRD
        (NP-SBJ (-NONE-:[510..510] *))
        (VP (TO:[511..513] to)
          (VP (VB:[514..523] elucidate)
            (NP
              (NP (DT:[524..527] the) (JJ:[528..543] transcriptional)
                  (NNS:[545..555] mechanisms))
              (PP (IN:[556..558] of)
                (NP (NN:[559..566] gastrin) (NN:[567..576] induction))))
            (PP (IN:[577..579] in)
              (NP (NN:[580..585] colon) (NN:[586..592] cancer)))))))
    (.:[592..593] .)))

;sentence 7 Span:594..602
;METHODS:
(SENT
  (NP (NNS:[594..601] METHODS) (::[601..602] :)))

;sentence 8 Span:603..722
;Gastrin messenger  (mRNA) levels and K-ras genotype were determined in colon
;cancer cell lines and  surgical specimens.
;[603..610]:gene-rna:"Gastrin"
;[640..645]:gene-rna:"K-ras"
;[674..686]:malignancy:"colon cancer"
(SENT
  (S
    (NP-SBJ-1
      (NP (NN:[603..610] Gastrin) (NN:[611..620] messenger)
        (PRN (-LRB-:[622..623] -LRB-)
          (NP (NN:[623..627] mRNA))
          (-RRB-:[627..628] -RRB-))
        (NNS:[629..635] levels))
      (CC:[636..639] and)
      (NP (NN:[640..645] K-ras) (NN:[646..654] genotype)))
    (VP (VBD:[655..659] were)
      (VP (VBN:[660..670] determined)
        (NP-1 (-NONE-:[670..670] *))
        (PP (IN:[671..673] in)
          (NP
            (NP
              (NML (NN:[674..679] colon) (NN:[680..686] cancer))
              (NN:[687..691] cell) (NNS:[692..697] lines))
            (CC:[698..701] and)
            (NP (JJ:[703..711] surgical) (NNS:[712..721] specimens))))))
    (.:[721..722] .)))

;sentence 9 Span:723..880
;Colon cancer cells were transfected with oncogenic ras  expression vectors,
;and transcriptional activity was assayed with  gastrin-luciferase reporter
;genes.
;[723..735]:malignancy:"Colon cancer"
;[774..777]:gene-rna:"ras"
;[846..853]:gene-rna:"gastrin"
;[854..864]:gene-rna:"luciferase"
(SENT
  (S
    (S
      (NP-SBJ-2
         (NN:[723..728] Colon) (NN:[729..735] cancer)
        (NNS:[736..741] cells))
      (VP (VBD:[742..746] were)
        (VP (VBN:[747..758] transfected)
          (NP-2 (-NONE-:[758..758] *))
          (PP (IN:[759..763] with)
            (NP (JJ:[764..773] oncogenic) (NN:[774..777] ras)
                (NN:[779..789] expression) (NNS:[790..797] vectors))))))
    (,:[797..798] ,) (CC:[799..802] and)
    (S
      (NP-SBJ-1 (JJ:[803..818] transcriptional) (NN:[819..827] activity))
      (VP (VBD:[828..831] was)
        (VP (VBN:[832..839] assayed)
          (NP-1 (-NONE-:[839..839] *))
          (PP (IN:[840..844] with)
            (NP
              (NML (NN:[846..853] gastrin) (HYPH:[853..854] -)
                   (NN:[854..864] luciferase))
              (NN:[865..873] reporter) (NNS:[874..879] genes))))))
    (.:[879..880] .)))

;sentence 10 Span:881..889
;RESULTS:
(SENT
  (NP (NNS:[881..888] RESULTS) (::[888..889] :)))

;sentence 11 Span:890..1033
;Colon cancer cell lines and tissues  with K-ras mutations all had
;significantly higher gastrin mRNA levels than those  that were ras wild
;type.
;[890..902]:malignancy:"Colon cancer"
;[932..937]:gene-rna:"K-ras"
;[977..984]:gene-rna:"gastrin"
;[1019..1022]:gene-rna:"ras"
(SENT
  (S
    (NP-SBJ
      (NP
        (NML (NN:[890..895] Colon) (NN:[896..902] cancer))
        (NN:[903..907] cell) (NNS:[908..913] lines))
      (CC:[914..917] and)
      (NP
        (NP (NNS:[918..925] tissues))
        (PP (IN:[927..931] with)
          (NP (NN:[932..937] K-ras) (NNS:[938..947] mutations)))))
    (ADVP (DT:[948..951] all))
    (VP (VBD:[952..955] had)
      (NP
        (NP
          (ADJP (RB:[956..969] significantly) (JJR:[970..976] higher))
          (NN:[977..984] gastrin) (NN:[985..989] mRNA) (NNS:[990..996] levels))
        (PP (IN:[997..1001] than)
          (NP
            (NP (DT:[1002..1007] those))
            (SBAR
              (WHNP-1 (WDT:[1009..1013] that))
              (S
                (NP-SBJ-1 (-NONE-:[1013..1013] *T*))
                (VP (VBD:[1014..1018] were)
                  (NP-PRD (NN:[1019..1022] ras) (JJ:[1023..1027] wild)
                          (NN:[1028..1032] type)))))))))
    (.:[1032..1033] .)))

;sentence 12 Span:1034..1207
;Treatment of several ras mutant cell lines with  PD98059, an inhibitor of
;mitogen-activated protein kinase kinase, resulted in a  decrease in
;endogenous gastrin mRNA levels.
;[1055..1058]:gene-rna:"ras"
;[1108..1147]:gene-protein:"mitogen-activated protein kinase kinase"
;[1187..1194]:gene-rna:"gastrin"
(SENT
  (S
    (NP-SBJ
      (NP (NN:[1034..1043] Treatment))
      (PP (IN:[1044..1046] of)
        (NP (JJ:[1047..1054] several) (NN:[1055..1058] ras)
            (JJ:[1059..1065] mutant) (NN:[1066..1070] cell)
            (NNS:[1071..1076] lines)))
      (PP (IN:[1077..1081] with)
        (NP
          (NP (NN:[1083..1090] PD98059))
          (,:[1090..1091] ,)
          (NP
            (NP (DT:[1092..1094] an) (NN:[1095..1104] inhibitor))
            (PP (IN:[1105..1107] of)
              (NP
                (ADJP (NN:[1108..1115] mitogen) (HYPH:[1115..1116] -)
                      (VBN:[1116..1125] activated))
                (NN:[1126..1133] protein) (NN:[1134..1140] kinase)
                 (NN:[1141..1147] kinase)))))))
    (,:[1147..1148] ,)
    (VP (VBD:[1149..1157] resulted)
      (PP-CLR (IN:[1158..1160] in)
        (NP
          (NP (DT:[1161..1162] a) (NN:[1164..1172] decrease))
          (PP (IN:[1173..1175] in)
            (NP (JJ:[1176..1186] endogenous) (NN:[1187..1194] gastrin)
                (NN:[1195..1199] mRNA) (NNS:[1200..1206] levels))))))
    (.:[1206..1207] .)))

;sentence 13 Span:1208..1437
;The effects of ras on gastrin  expression appeared to be mediated through the
;gastrin promoter because  transfection of oncogenic ras and activated raf
;expression vectors both induced  gastrin-promoter, luciferase-reporter
;genes.
;[1223..1226]:gene-rna:"ras"
;[1230..1237]:gene-protein:"gastrin"
;[1286..1293]:gene-rna:"gastrin"
;[1338..1341]:gene-rna:"ras"
;[1356..1359]:gene-rna:"raf"
;[1393..1400]:gene-rna:"gastrin"
;[1411..1421]:gene-rna:"luciferase"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[1208..1211] The) (NNS:[1212..1219] effects))
      (PP (IN:[1220..1222] of)
        (NP (NN:[1223..1226] ras)))
      (PP (IN:[1227..1229] on)
        (NP (NN:[1230..1237] gastrin) (NN:[1239..1249] expression))))
    (VP (VBD:[1250..1258] appeared)
      (S
        (NP-SBJ-1 (-NONE-:[1258..1258] *))
        (VP (TO:[1259..1261] to)
          (VP (VB:[1262..1264] be)
            (VP (VBN:[1265..1273] mediated)
              (NP-1 (-NONE-:[1273..1273] *))
              (PP (IN:[1274..1281] through)
                (NP (DT:[1282..1285] the) (NN:[1286..1293] gastrin)
                    (NN:[1294..1302] promoter)))))))
      (SBAR-PRP (IN:[1303..1310] because)
        (S
          (NP-SBJ
            (NP (NN:[1312..1324] transfection))
            (PP (IN:[1325..1327] of)
              (NP
                (NP (JJ:[1328..1337] oncogenic) (NN:[1338..1341] ras))
                (CC:[1342..1345] and)
                (NP (VBN:[1346..1355] activated) (NN:[1356..1359] raf)
                    (NN:[1360..1370] expression) (NNS:[1371..1378] vectors)))))
          (ADVP (DT:[1379..1383] both))
          (VP (VBD:[1384..1391] induced)
            (NP
              (NML
                (NML (NN:[1393..1400] gastrin) (HYPH:[1400..1401] -)
                     (NN:[1401..1409] promoter))
                (,:[1409..1410] ,)
                (NML (NN:[1411..1421] luciferase) (HYPH:[1421..1422] -)
                     (NN:[1422..1430] reporter)))
              (NNS:[1431..1436] genes))))))
    (.:[1436..1437] .)))

;sentence 14 Span:1438..1585
;The inductive effects of oncogenic  ras could be blocked by the coexpression
;of dominant negative forms of raf and  extracellular regulated kinase.
;[1474..1477]:gene-rna:"ras"
;[1545..1548]:gene-generic:"raf"
;[1578..1584]:gene-protein:"kinase"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[1438..1441] The) (JJ:[1442..1451] inductive)
          (NNS:[1452..1459] effects))
      (PP (IN:[1460..1462] of)
        (NP (JJ:[1463..1472] oncogenic) (NN:[1474..1477] ras))))
    (VP (MD:[1478..1483] could)
      (VP (VB:[1484..1486] be)
        (VP (VBN:[1487..1494] blocked)
          (NP-1 (-NONE-:[1494..1494] *))
          (PP (IN:[1495..1497] by)
            (NP-LGS
              (NP (DT:[1498..1501] the) (NN:[1502..1514] coexpression))
              (PP (IN:[1515..1517] of)
                (NP
                  (NP
                    (NP (JJ:[1518..1526] dominant) (JJ:[1527..1535] negative)
                        (NNS:[1536..1541] forms))
                    (PP (IN:[1542..1544] of)
                      (NP (NN:[1545..1548] raf))))
                  (CC:[1549..1552] and)
                  (NP (JJ:[1554..1567] extracellular)
                      (VBN:[1568..1577] regulated) (NN:[1578..1584] kinase)))))))))
    (.:[1584..1585] .)))

;sentence 15 Span:1586..1598
;CONCLUSIONS:
(SENT
  (NP (NNS:[1586..1597] CONCLUSIONS) (::[1597..1598] :)))

;sentence 16 Span:1599..1712
;Oncogenic ras induces gastrin gene  expression through activation of the
;Raf-MEK-ERK signal transduction pathway.
;[1609..1612]:gene-rna:"ras"
;[1621..1628]:gene-rna:"gastrin"
;[1672..1675]:gene-rna:"Raf"
;[1676..1679]:gene-rna:"MEK"
;[1680..1683]:gene-rna:"ERK"
(SENT
  (S
    (NP-SBJ (JJ:[1599..1608] Oncogenic) (NN:[1609..1612] ras))
    (VP (VBZ:[1613..1620] induces)
      (NP (NN:[1621..1628] gastrin) (NN:[1629..1633] gene)
          (NN:[1635..1645] expression))
      (PP (IN:[1646..1653] through)
        (NP
          (NP (NN:[1654..1664] activation))
          (PP (IN:[1665..1667] of)
            (NP (DT:[1668..1671] the)
              (NML (NN:[1672..1675] Raf) (HYPH:[1675..1676] -)
                   (NN:[1676..1679] MEK) (HYPH:[1679..1680] -)
                   (NN:[1680..1683] ERK))
              (NML (NN:[1684..1690] signal) (NN:[1691..1703] transduction))
              (NN:[1704..1711] pathway))))))
    (.:[1711..1712] .)))

;section 17 Span:1716..1760
;PMID: 9797369 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1716..1720] PMID) (::[1720..1721] :) (CD:[1722..1729] 9797369)
        (IN:[1730..1731] -LSB-) (NNP:[1731..1737] PubMed) (HYPH:[1738..1739] -)
        (JJ:[1740..1747] indexed) (IN:[1748..1751] for)
        (NNP:[1752..1760] MEDLINE-RSB-)))
